Cargando…
The Antagonism of Neuropeptide Y Type I Receptor (Y1R) Reserves the Viability of Bone Marrow Stromal Cells in the Milieu of Osteonecrosis of Femoral Head (ONFH)
Neuropeptide Y (NPY)-Y1 receptor (Y1R) signaling is known to negatively affect bone anabolism. Our study aimed at investigating the impact of NPY-Y1R signaling in the pathogenesis of glucocorticoid-related osteonecrosis of the femoral head (ONFH). Femoral heads were retrieved from 20 patients with a...
Autores principales: | Ko, Jih-Yang, Wang, Feng-Sheng, Chen, Sung-Hsiung, Wu, Re-Wen, Hsu, Chieh-Cheng, Kuo, Shu-Jui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687204/ https://www.ncbi.nlm.nih.gov/pubmed/36428510 http://dx.doi.org/10.3390/biomedicines10112942 |
Ejemplares similares
-
Runx2 overexpression promotes bone repair of osteonecrosis of the femoral head (ONFH)
por: Xu, Hai-Jia, et al.
Publicado: (2023) -
Administration of mircoRNA‐135b‐reinforced exosomes derived from MSCs ameliorates glucocorticoid‐induced osteonecrosis of femoral head (ONFH) in rats
por: Zhang, Xiang, et al.
Publicado: (2020) -
Mid- to long-term results of modified avascular fibular grafting for ONFH
por: Yuan, Peng, et al.
Publicado: (2021) -
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
por: Yang, Chieh-Hsin, et al.
Publicado: (2021) -
Correlation between the efficacy of stem cell therapy for osteonecrosis of the femoral head and cell viability
por: Wu, Zhan Yu, et al.
Publicado: (2020)